Position in KRYS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$756,348
+$239,708 QoQ
Shares Held
2,035
+1.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#211
of 419 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. KRYS ranks #72 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in KRYS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $756,348 | 2,035 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $516,640 | 2,000 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $2,359,676 | 13,367 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,400,326 | 17,462 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $346,176 | 1,920 | Shares | Defined | 2025-04-30 | |
| 2024-09-30 | $4,072,375 | 22,372 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,089,662 | 22,270 | Shares | Defined | 2024-08-13 | |
| 2023-09-30 | $2,391,920 | 20,620 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,375,706 | 20,236 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,359,178 | 16,977 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,381,913 | 17,444 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $978,657 | 14,041 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $998,754 | 15,211 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,724,251 | 25,913 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,015,889 | 28,819 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,420,790 | 27,213 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,988,388 | 29,241 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,746,784 | 35,654 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $2,132,580 | 35,543 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $1,079,521 | 25,076 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $982,440 | 23,719 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,360,762 | 31,470 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||